Lactobacillus bulgaricus and extracellular polysaccharide thereof, and preparation method and application of extracellular polysaccharide
Through the isolated Lactobacillus Bulgarian KLDS1.1103 from traditional dairy products in Xinjiang and the optimized fermentation conditions, the production and fermentation efficiency of EPS were improved, the problem of low EPS yield of Lactobacillus Bulgarian was solved, and high-efficiency and low-energy consumption polysaccharide preparation was achieved. and demonstrates its anti-inflammatory and barrier-protecting effects.
Patent Information
- Application Number
- CN202410990907.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-23
- Publication Date
- 2024-11-15
AI Technical Summary
Lactobacillus Bulgaria has low EPS yield and fermentation efficiency, high energy consumption, and it is difficult for the existing technology to screen and develop new bacterial strains and EPS production technologies with active and high yield.
Lactobacillus Bulgarian KLDS1.1103 was isolated from traditional dairy products in Xinjiang, and its extracellular polysaccharide was prepared by batch fermentation method. The optimization of fermentation conditions included the use of 2.0%-3.0% inulin and the fermentation temperature was 35℃-43 °C, without stirring aerobic fermentation, inoculation volume 4%-12%, fermentation time 6-10 hours.
Improve the fermentation production efficiency and yield of Lactobacillus Bulgaria extracellular polysaccharides, reduce energy consumption, the output can exceed 690mg/L, and the fermentation efficiency exceeds 77mg/L/h. The polysaccharides have anti-inflammatory and tight junction protein upregulation effects, which can alleviate Diseases caused by increased permeability of the intestinal barrier and blood-brain barrier.
Smart Images

Figure CN118956652A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of microorganisms, and in particular relates to a Lactobacillus bulgaricus and an exopolysaccharide thereof, and a preparation method and application of the exopolysaccharide. Background Art
[0002] Exopolysaccharide (EPS) is a secondary metabolite of microorganisms. The activities of exopolysaccharides isolated from different microorganisms vary greatly due to the differences in their complex structural factors such as monosaccharide composition, glycosidic bond composition, and three-dimensional structure. So far, there is still a lack of systematic research and clear regular guidance on the structure-activity relationship of polysaccharides. CN109295126A discloses an EPS of Lactobacillus plantarum, which was found to have an immunomodulatory effect; EPS of some thermophilic Streptococcus, more Lactobacillus plantarum, and very few Lactobacillus bulgaricus were found to upregulate the tight junction proteins of cells, which is beneficial to protect the intestinal barrier and blood-brain barrier and reduce its permeability. For example, EPS of Lactobacillus plantarum 1.0386, BGAN8, HY771, T10, etc. were all found to have the effect of protecting the intestinal barrier. The surface protein of Lactobacillus plantarum 1.0386, rather than EPS, has the function of protecting the intestinal barrier (Zhang, et al. Postbiotics derived from Lactobacillus plantarum 1.0386amelioratelipopolysaccharide-induced tight junction injury via MicroRNA-200c-3pmediated activation of the MLCK-MLC pathway in Caco-2 cells. Food & Function, 2022), while of Lactobacillus bulgaricus, only the EPS of OLL1073R-1 strain has been found to upregulate the tight junction proteins of cells (. Ishikawa, et al. Exopolysaccharides from Lactobacillus delbrueckiissp.bulgaricus OLL1073R-1prevent influenza virus infection and attenuatesecondary bacterial infection risk. Letters in Applied Microbiology, 2022). However, the active natural polysaccharides discovered so far do not exceed 2%. Most polysaccharides with outstanding biological activity are connected by (1,3) glycosidic bonds, especially polysaccharides with β-(1,3) glycosidic bonds (Qian Qing, Zhang Zhiyong. Research progress on the pharmacological effects and applications of plant active polysaccharides. West China Medical Science, 2009).
[0003] Lactobacillus delbrueckii subsp. Bularicus belongs to lactobacillus. Due to its origin and microbial characteristics, it is also called Lactobacillus delbrueckii subsp. Bularicus (referred to as Lactobacillus bulgaricus). It is usually used in yogurt fermentation to decompose lactose into glucose and galactose, and finally into lactic acid. It is beneficial for people with lactose intolerance. The EPS of Lactobacillus bulgaricus can play a gelling and thickening role, giving fermented dairy products a special texture and flavor, and has thickening, stabilizing, emulsifying, gelling and water-holding effects. However, the EPS production and fermentation efficiency of Lactobacillus bulgaricus are generally low. The EPS production of most strains in batch fermentation is less than 450 mg / L (Ali, et al. Isolation and characterization of exopolysaccharide-producing strains of Lactobacillus bulgaricus from curd. Food Science & Nutrition, 2019). When strong pulsed light is added, some strains can reach a production of 500 mg / L in batch fermentation, but the energy consumption and operation requirements are high, which is not conducive to popularization. Some strains can also achieve an EPS production of 900 mg / L in batch fermentation, but the fermentation temperature reaches 42°C, the fermentation time is long, and the fermentation efficiency is about 50 mg / L / h (Wang Qingmei, Chen Qingsen, Yan Yali. Optimization of the culture conditions for the fermentation of exopolysaccharides by Lactobacillus delbrueckii subspecies NCFB2772 by response surface methodology. Dairy Science and Technology, 2011). Therefore, the energy consumption is still high and the fermentation efficiency is still low.
[0004] Therefore, this field still needs to screen and develop relevant new strains and EPS production technologies to obtain beneficial active EPS, increase EPS production and fermentation efficiency, and reduce energy consumption. Summary of the invention
[0005] In view of the above problems, the inventors newly isolated a kind of Lactobacillus bulgaricus from traditional dairy products in Xinjiang, named as Lactobacillus bulgaricus KLDS1.1103 (L.bulgaricus KLDS1.1103), and prepared a kind of Lactobacillus bulgaricus exopolysaccharide using the Lactobacillus bulgaricus, and found that the polysaccharide has good anti-inflammatory and tight junction protein up-regulation effects, which is beneficial to protect mammalian barriers such as intestinal barrier and blood-brain barrier, thereby alleviating diseases or discomfort caused by increased permeability of intestinal barrier and blood-brain barrier. The Lactobacillus bulgaricus exopolysaccharide prepared using the Lactobacillus bulgaricus has the advantages of high fermentation production efficiency and low energy consumption, and has good industrial promotion value.
[0006] Therefore, the present invention first provides a Lactobacillus bulgaricus, which is isolated from traditional dairy products in Xinjiang. The preservation date of the Lactobacillus bulgaricus is April 25, 2024, and the preservation unit is the General Microbiology Center of the China Microbiological Culture Collection Administration Committee. The preservation address is No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, and the preservation number is CGMCC No. 30436. The taxonomic name is: Lactobacillus bulgaricus, that is, Lactobacillus delbrueckii subsp.bulgaricus strain.
[0007] Preferably, the gene sequence of 16S rDNA of Lactobacillus bulgaricus is shown as SEQ ID NO.1.
[0008] The present invention further provides a Lactobacillus bulgaricus exopolysaccharide prepared by fermentation of Lactobacillus bulgaricus with a preservation number of CGMCC No. 30436. Monosaccharide analysis shows that the exopolysaccharide is mainly composed of mannose, rhamnose, glucuronic acid, galacturonic acid, glucose, galactose, arabinose and fucose, wherein glucose and galactose account for 98.21% (mass percentage) of the exopolysaccharide content, and the molar ratio of glucose to galactose is 1.053:1. Gel chromatography and other molecular weight determinations show that the weight average molecular weight Mw of the exopolysaccharide is 4.06×10 4 Da, number average molecular weight Mn is 1.59×10 4 Da, the polydispersity coefficient Mw / Mn is 2.57. Infrared spectrum functional group analysis shows that the infrared spectrum of the extracellular polysaccharide is 3401.85cm -1 、2922.92cm -1 、1665.99cm -1 、1540.70cm -1 、1421.48cm -1 、1243.65cm -1 、1039.55cm -1 、892.03cm -1 、584.87cm -1 There is an absorption peak at.
[0009] Based on the preparation process research of the inventor, the present invention further provides a preparation method of a Lactobacillus bulgaricus exopolysaccharide obtained by fermenting Lactobacillus bulgaricus with the deposit number CGMCCNo.30436, the preparation method is a batch fermentation method, the fermentation medium used in the batch fermentation method is a skim milk medium containing 2.0% to 3.0% inulin; the inoculation amount is 4% to 12%, the fermentation temperature is 35°C to 43°C, the fermentation time is 6 to 10 hours, and the fermentation conditions are aerobic fermentation without stirring. That is, the fermentation medium used in the batch fermentation method is to add 2.0g to 3.0g of inulin to every 100mL of skim milk medium.
[0010] Preferably, the fermentation medium used in the batch fermentation method is a skim milk medium containing 2.0% to 2.1% inulin. Further preferably, the fermentation medium used in the batch fermentation method is a skim milk medium containing 2.1% inulin.
[0011] Preferably, the inoculation amount is 10%, the fermentation temperature is 39° C., and the fermentation time is 9 hours.
[0012] The "non-stirring aerobic fermentation" refers to fermentation under aerobic conditions, but no additional stirring operation is performed during the fermentation process.
[0013] Based on the activity research of the inventors, the present invention further provides the use of a Lactobacillus bulgaricus exopolysaccharide prepared by fermenting the Lactobacillus bulgaricus with a deposit number of CGMCC No. 30436, including:
[0014] (1) The use of the extracellular polysaccharide in the preparation of an active agent for invoking tight junction-associated proteins in mammalian cells, namely, for upregulating tight junction-associated proteins in mammalian cells.
[0015] (2) Use of the extracellular polysaccharide in the preparation of an active agent for preventing or alleviating intestinal barrier damage and / or blood-brain barrier damage caused by down-regulation of tight junction-associated proteins, i.e., for up-regulating tight junction-associated proteins in mammalian cells, thereby alleviating mammalian intestinal barrier damage and / or blood-brain barrier damage.
[0016] Preferably, the active agent includes a preventive or therapeutic drug, a dietary supplement, or the like.
[0017] Preferably, the tight junction-associated proteins at least include Occludin protein and / or ZO-1 protein.
[0018] Preferably, the active agent is an oral preparation.
[0019] According to the research results, the extracellular polysaccharides obtained by fermentation of Lactobacillus bulgaricus KLDS1.1103 (L.bulgaricus KLDS1.1103) have an upregulating effect on the expression of at least two tight junction-related proteins, Occludin protein and ZO-1 protein, and can thus be used to alleviate intestinal barrier damage and / or blood-brain barrier damage caused by downregulation of tight junction-related proteins.
[0020] The Lactobacillus bulgaricus KLDS1.1103 (L.bulgaricus KLDS1.1103) described in the present invention is isolated from traditional dairy products in Xinjiang. The preservation date of the Lactobacillus bulgaricus is April 25, 2024, and the preservation unit is the General Microbiology Center of the China Microbiological Culture Collection Administration Committee. The preservation address is No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, and the preservation number is CGMCC No.30436. The taxonomic name is: Lactobacillus bulgaricus, that is, Lactobacillus delbrueckii subsp.bulgaricus strain.
[0021] Its applicable culture medium and morphological characteristics are as follows:
[0022] Lactobacillus bulgaricus KLDS1.1103 was cultured in MRS medium for three generations, and the colony morphology was round, light yellow, opaque, smooth, with neat edges and a diameter of 1-2 mm. The MRS medium formula was: peptone 5.0 g / L, tryptone 10.0 g / L, sodium acetate 5.0 g / L, dipotassium hydrogen phosphate 2.0 g / L, glucose 20.0 g / L, yeast powder 5.0 g / L, manganese sulfate 0.25 g / L, magnesium sulfate 0.58 g / L, diammonium hydrogen citrate 2.0 g / L, Tween-80 1.0 g / L, beef extract 5.0 g / L. The first and second generations of the strain were cultured for 24 hours, and the third generation was cultured for 18 hours.
[0023] The strain isolation and purification process requires plating on solid mMRS agar medium. mMRS agar medium formula: add 1.6% agar to mMRS medium.
[0024] The beneficial effects of the present invention include:
[0025] (1) The Lactobacillus bulgaricus KLDS1.1103 of the present invention has the advantage of high extracellular polysaccharide fermentation production efficiency.
[0026] (2) The obtained Lactobacillus bulgaricus exopolysaccharide can exert anti-inflammatory effects and upregulate Occludin mRNA and ZO-1 mRNA at relatively low concentrations, and can reach a level that is not significantly different from that of the normal control, which is beneficial for alleviating intestinal barrier damage and / or blood-brain barrier damage by regulating Occludin protein and ZO-1 protein.
[0027] (3) The obtained Lactobacillus bulgaricus exopolysaccharide has high thermodynamic stability and can withstand high temperature sterilization when used as a pharmaceutical product or dietary supplement.
[0028] (4) The Lactobacillus bulgaricus exopolysaccharide fermentation process of the present invention has the advantages of low fermentation temperature, fast fermentation production speed and high yield. The yield can exceed 690 mg / L, and the fermentation efficiency can exceed 77 mg / L / h, which greatly improves the fermentation efficiency of the Lactobacillus bulgaricus exopolysaccharide batch fermentation process and is beneficial to energy saving and consumption reduction. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 HPLC chart of monosaccharide analysis in Example 3;
[0030] Figure 2 The result of gel chromatography in Example 3 is shown in FIG.
[0031] Figure 3 The result of infrared spectrum analysis of Example 3 is shown in FIG.
[0032] Figure 4 This is a diagram showing the results of differential scanning calorimetry analysis of Example 3. DETAILED DESCRIPTION
[0033] The present invention will be further described below in conjunction with the embodiments.
[0034] If not otherwise specified, in the embodiments of the present invention, the method for separating and purifying the extracellular polysaccharide (EPS) of Lactobacillus bulgaricus KLDS1.1103 is as follows: after the EPS is fermented to curd, it is taken out and post-ripened at 4°C, the fermentation liquid is placed in boiling water and heated for 10 minutes to degrade and consume the EPS enzyme activity, after cooling to room temperature, it is centrifuged at 4°C and 8000r / min for 6 minutes, and the clarified supernatant is collected by filtration. 80% (w / v) trichloroacetic acid was added to the supernatant to a final concentration of 4% (w / v), and the mixture was placed at 4°C for precipitation for 12 hours, centrifuged at 4°C and 8000 rpm for 20 minutes to remove protein precipitates, and the clarified supernatant was collected by suction filtration, and rotary evaporated to 1 / 3 of the volume, and three times the volume of anhydrous ethanol was added to the supernatant, and the mixture was placed at 4°C for precipitation overnight for 12 hours, and centrifuged at 4°C and 8000 rpm for 6 minutes. The clarified sugar solution was collected and placed in a dialysis bag for 48 hours, and the water was changed every 8 hours. The dialyzed solution was collected, concentrated by rotary evaporation, and frozen at -80°C. After freeze-drying for 12 hours, dry EPS powder was obtained. When the yield is measured, the extracellular polysaccharide content (mg / L) can be calculated based on the volume of the fermentation liquid after measuring the weight of EPS.
[0035] Example 1 Isolation and Identification of Lactobacillus bulgaricus KLDS1.1103
[0036] Isolation, Purification and Identification of Lactobacillus delbrueckii subsp. bulgaricus
[0037] 1 Isolation and purification of Lactobacillus bulgaricus KLDS1.1103
[0038] Take 1g of Xinjiang traditional fermented sour mare's milk and 9ml of phosphate buffer solution, mix thoroughly and dilute in gradient, then spread on mMRS agar solid culture medium, culture at 37℃ for 48h, observe and record the colony morphology; pick the white and yellowish colonies with smooth surface, protrusions and purify and culture at 37℃, repeat this operation 3 times to obtain the purified single colony, pick the purified single colony to form a line on mMRS agar solid culture medium, and culture at 37℃ for 48h.
[0039] The formula of MRS medium is: peptone 5.0g / L, tryptone 10.0g / L, sodium acetate 5.0g / L, dipotassium hydrogen phosphate 2.0g / L, glucose 20.0g / L, yeast powder 5.0g / L, manganese sulfate 0.25g / L, magnesium sulfate 0.58g / L, diammonium hydrogen citrate 2.0g / L, Tween-80 1.0g / L, and beef extract 5.0g / L.
[0040] mMRS agar medium recipe: Add 1.6% agar to mMRS medium.
[0041] 2. Identification of Lactobacillus bulgaricus KLDS1.1103
[0042] The genome of the strain after separation and purification was extracted, and the 16S rDNA of the strain was amplified and sequenced. The nucleotide sequence of the amplified 16S rDNA was shown in SEQ ID NO.1. The obtained sequence was compared with the nucleotide sequence in NCBI-Blast, and the result showed that the strain was Lactobacillus delbrueckii subsp. bulgaricus strain, namely Lactobacillus bulgaricus.
[0043] The strain has been deposited on April 25, 2024, with the General Microbiology Center of China Microbiological Culture Collection Administration, and the deposit address is No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, and the deposit number is CGMCC No. 30436. The taxonomic name is: Lactobacillus bulgaricus, that is, Lactobacillus delbrueckii subsp.bulgaricus strain.
[0044] Example 2 Study on the fermentation process of Lactobacillus bulgaricus KLDS1.1103EPS
[0045] 1. Single factor investigation of EPS fermentation process of Lactobacillus bulgaricus KLDS1.1103
[0046] The activation of Lactobacillus bulgaricus KLDS1.1103 before inoculation was cultured in MRS medium at 37°C. Skim milk medium was used for strain fermentation and single factor investigation of KLDS1.1103 EPS fermentation process.
[0047] (1) Selection of carbon source for KLDS1.1103 EPS fermentation
[0048] Glucose, fructose, sucrose, maltose, galacto-oligosaccharide, inulin, oligofructose and mixed carbon sources were selected and added to skim milk medium. The amount of carbon source added to each 100 mL skim milk medium was 2.1 g, of which the mixed carbon source consisted of 0.3 g of each carbon source (i.e., 7 carbon sources totaling 2.1 g). After the medium was sterilized, the activated strain was inoculated with an inoculum of 8%, and the initial pH of the medium was 5.7 ± 0.2 (replacing the vague word "about"), and the liquid volume was consistent. Preliminary experiments showed that stirring caused the strain to undergo long-term aerobic respiration, which in turn caused a reduction in EPS production. Therefore, this experiment used a constant temperature aerobic fermentation without stirring at 37 ° C for 24 h to extract KLDS 1.1103 EPS, and the weight was measured after freeze-drying, and the KLDS1.1103 EPS production (mg / L) was calculated based on the volume of the fermentation liquid. As shown in Table 1, among various skim milk culture media, the EPS yield of KLDS1.1103 with inulin added was the highest, reaching about 538.33 mg / L, which was significantly higher than the other carbon sources (p<0.05). When glucose was used as a carbon source, the EPS yield was only about 109.67 mg / L. When different carbon sources were used, the EPS yield from high to low was: inulin> mixed carbon source> sucrose> fructose> maltose> galacto-oligosaccharide> glucose, and there was no significant difference between galacto-oligosaccharide and fructo-oligosaccharide (p>0.05).
[0049] Studies have shown that most lactic acid bacteria can only metabolize sucrose, lactose and glucose (see reference 1: Tang Zongxin, Yang Shuo, Duan Bofan, Chen Yuhan, Meng Xiangchen. Analysis of the post-acidification properties of Lactobacillus bulgaricus based on the sucrose metabolic pathway. Modern Food Science and Technology, 2023, 39(12): 142-150.). This study unexpectedly found that the utilization rate of inulin by Lactobacillus bulgaricus KLDS1.1103 was significantly better than that of sucrose, and it contributed greatly to the fermentation production of KLDS1.1103 EPS, reaching nearly twice the yield when sucrose was used as a carbon source.
[0050] (2) Optimization of KLDS1.1103 EPS fermentation inoculation amount
[0051] The activated strains were inoculated at volume ratios of 4%, 6%, 8%, 10%, and 12%, respectively, and the amount of inulin added was 2.1 g / 100 mL skim milk medium. After aerobic fermentation at 37°C for 5 hours without stirring until the milk curdled, it was placed at 4°C for post-ripening for 20 hours. The KLDS1.1103EPS was extracted and freeze-dried, and its weight was measured. The KLDS1.1103EPS yield (mg / L) was calculated based on the volume of the fermentation liquid. As shown in Table 1, the inoculation amount is an important factor affecting the yield of KLDS1.1103EPS. As the inoculation amount increases, the yield increases. The maximum value of 676.5±21.58 mg / L was reached when the inoculation amount was 10%. When the inoculation amount exceeds 10%, due to the excessive number of strains and the rapid metabolic development, competitive inhibition occurs, resulting in a decrease in yield.
[0052] (3) Optimization of KLDS1.1103 EPS fermentation temperature
[0053] The activated strain was inoculated with 8% inoculum, and the fermentation was carried out at 35℃, 37℃, 39℃, 41℃, and 43℃ for 5h without stirring and then placed at 4℃ for 20h. The amount of inulin added was 2.1g. The weight of KLDS 1.1103 EPS was measured after extraction and freeze-drying, and the KLDS1.1103 EPS yield (mg / L) was calculated according to the volume of the fermentation liquid. As shown in Table 1, when the fermentation temperature was within the range of 35℃ to 39℃, the KLDS1.1103 EPS yield gradually increased with the increase of temperature, reaching a maximum value of 663.83±17.79mg / L at 39℃. When the fermentation temperature was between 39℃ and 43℃, the yield decreased significantly with the increase of temperature (p<0.05). The optimum growth temperature of Lactobacillus bulgaricus KLDS1.1103 was about 37℃, but the temperature corresponding to the maximum EPS yield was 39℃.
[0054] (4) Optimization of KLDS1.1103 EPS fermentation time
[0055] The activated strain was inoculated with an inoculum of 8%, and the inulin addition amount was 2.1g / 100mL skim milk medium and 37℃. The aerobic fermentation was carried out at constant temperature without stirring for 6h, 7h, 8h, 9h, and 10h until the milk was coagulated, and then it was placed at 4℃ for post-ripening for 20h. The weight of KLDS1.1103EPS was measured after extraction and freeze-drying. The KLDS 1.1103EPS yield (mg / L) was calculated according to the volume of the fermentation liquid. As shown in Table 1, the KLDS1.1103EPS yield gradually increased with the extension of fermentation time. When the fermentation time was 9h, the KLDS1.1103EPS yield was the largest, reaching 670.5±31.54mg / L. The decrease in yield at 10h of fermentation may be related to the decrease in pH caused by the continuous growth of the strain.
[0056] Table 1 Single factor investigation results of KLDS1.1103 EPS fermentation process
[0057]
[0058]
[0059] 2. Determination of KLDS1.1103 EPS fermentation process
[0060] On the basis of the first part of this embodiment, inulin was selected as the carbon source, and the amount of carbon source added to each 100 mL skim milk medium was 2.1 g. Three better levels of the three factors of inoculation amount, fermentation time and fermentation temperature were selected, and KLDS1.1103EPS yield was used as the evaluation index, and 17 exploration experiments were carried out. The experimental results are shown in Table 2, where the three independent variables A, B, and C represent the fermentation time, fermentation temperature, and inoculation amount, respectively. The three factor levels of -1, 0, and 1 in A represent 8h, 9h, and 10h, respectively, the three factor levels of -1, 0, and 1 in B represent 37°C, 39°C, and 41°C, respectively, and the three factor levels of -1, 0, and 1 in C represent 8%, 10%, and 12%, respectively.
[0061] Table 2 EPS yield of KLDS1.1103 in 17 experiments
[0062]
[0063] The conditions of test numbers 13 to 17 were fermentation time of 9 hours, fermentation temperature of 39°C, and inoculation size of 10%. The average KLDS1.1103EPS yield of the five tests was 693.6 mg / L, which was more than 6.3 times the yield of the first part with 2.1% glucose as the carbon source (i.e., 2.1 g of glucose was added to every 100 mL of culture medium), 8% inoculation size, and fermentation at 37°C for 24 hours.
[0064] Example 3 Structural analysis and thermal stability of Lactobacillus bulgaricus KLDS1.1103 EPS
[0065] 1. Monosaccharide analysis of EPS
[0066] After the KLDS1.1103 EPS sample was dried, anhydrous glucose was used as the standard, and the neutral sugar content of EPS was determined by the sulfuric acid phenol method. The monosaccharide composition of EPS was determined by HPLC, and the method was as follows:
[0067] Take KLDS1.1103EPS sample, add trifluoroacetic acid, and hydrolyze at 105℃ for 6h under nitrogen sealing conditions. After the hydrolysis is completed, spin dry, add methanol and wash repeatedly three times to prepare a mixed standard reference solution containing 50μg of monosaccharide per 1mL. Add 250μL0.6mol / LNaOH and 500μL 0.4mol / L PMP-methanol (PMP is 1-phenyl-3-methyl-5-pyrazolone) to 250μL mixed reference solution and sample solution, and react at 70℃ for 1h. Add 500μL 0.3mol / L HCl for neutralization, then add 1mL chloroform and vortex for 1min. Centrifuge at 3000r / min for 10min and extract, collect the supernatant, repeat the extraction 3 times, filter the supernatant through a 0.22μm membrane and perform HPLC. The HPLC setting program is as follows: the chromatographic column is XtimateC18 4.6×200mm 5μm, the column temperature is 30℃; the flow rate is 1.0mL / min; the injection volume is 20μL; the mobile phase is 0.05mol / L potassium dihydrogen phosphate solution (pH is 6.70): acetonitrile = 83:17.
[0068] Results Figure 1 . Figure 1 A is the HPLC standard curve of the mixed monosaccharide standard. The peaks of each standard are well separated, and their peak retention times (RT, min) are as follows from small to large: mannose (14.112), ribose (18.270), rhamnose (19.113), glucuronic acid (23.137), galacturonic acid (26.361), N-acetyl-glucosamine (27.409), glucose (30.293), N-acetylgalactosamine (31.714), galactose (34.688), xylose (36.421), arabinose (37.820) and fucose (43.296). Figure 1 B is the HPLC chromatogram of the KLDS1.1103EPS sample. Comparative analysis shows that the EPS is mainly composed of mannose (RT=14.139min), rhamnose (RT=19.217min), glucuronic acid (RT=23.262min), galacturonic acid (RT=26.003min), glucose (RT=30.217min), galactose (RT=34.582min), arabinose (RT=37.939min) and fucose (RT=42.944min), of which glucose and galactose account for 98.21% of the total polysaccharide content, and the molar ratio is 1.053:1.
[0069] 2. Analysis of EPS molecular weight
[0070] Take KLDS1.1103EPS sample and analyze the molecular weight by gel chromatography. Take 10mg of EPS sample, dissolve it in 1mL of deionized water to prepare a solution, filter it with a 0.45μm membrane, inject 100μL of filtrate into the GPC chromatography group with a micro syringe, and use narrow distribution polyethylene glycol (PEO) as a standard. The mobile phase is 0.1M NaNO3+NaN3 solution, the flow rate is 0.6mL / min, the column temperature is 35℃, and the instrument is equipped with a Shimadzu RID-20 differential refractometer and a TOSOH TSKgel GMPWXL aqueous gel chromatography column. The weight average molecular weight Mw of KLDS1.1103EPS is 4.06×10 4 Da, number average molecular weight Mn is 1.59×10 4 Da, the polydispersity coefficient Mw / Mn is Mw / Mn is 2.57. Figure 2 It can be seen that the signal peak is bimodal, indicating that KLDS1.1103EPS is heterogeneous, there are different molecules in the system that have not aggregated, and the molecular weights of different molecules are quite different. In addition, its polydispersity coefficient is large, which further proves that there are multiple polysaccharides with different molecular weights in EPS.
[0071] 3. Functional group analysis of EPS
[0072] KLDS1.1103EPS sample was taken and its functional group composition was analyzed by infrared spectrometry. The characteristic groups and glycosidic bonds in the molecule were evaluated by Fourier transform infrared spectroscopy (FT-IR) (Shimadzu-8400s, Japan). In addition, EPS was ground with KBr powder (EPS:KBr is about 1:100) and flattened into transparent sheets for 400 cm -1 and 4000cm -1 The results are shown in the infrared spectrum of Figure 3 .Depend on Figure 3 It can be seen that KLDS1.1103EPS is 3401.85cm -1 (strong absorption peak), 2922.92cm -1 、1665.99cm -1 、1540.70cm -1 、1421.48cm -1 、1243.65cm -1 、1039.55cm -1 (strong absorption peak), 892.03cm -1 、584.87cm -1 There is an absorption peak at 1243.65cm -1 -1421.48cm -1 There are a few absorption peaks in the range of 780.89 cm-1 、831.4cm -1 There is also an absorption peak at .
[0073] The EPS has a significant polysaccharide characteristic absorption peak. 3401.85cm -1 The strong absorption peak at 2922.92cm is caused by the stretching vibration of -OH, indicating the presence of a large number of hydroxyl groups. -1 The obvious absorption peak at 1243.65cm is caused by the stretching vibration of the CH bond. -1 ~1421.48cm -1 A small amount of absorption peaks may be caused by the angular vibration of CH, 1665.99cm -1 The absorption peak at 1243.65cm may be caused by the asymmetric stretching vibration of the carbonyl group. EPS may contain a small amount of uronic acid, which is consistent with the monosaccharide composition results. -1 The small absorption peak is caused by the stretching vibration of -OH in the carboxyl group. 1421.48cm -1 Located at 1398cm -1 -1443cm -1 It may be related to the stretching vibration of CO bond. -1 -1200cm -1 1039.55cm between -1 There is a strong absorption peak at 892.03cm, which may represent the stretching vibration of the COC bond and -OH bond in the pyran ring. -1 The absorption peak near 584.87 cm -1 A series of absorption peaks nearby indicate that the EPS contains -glycoside chains.
[0074] 4.Analysis of thermal stability of EPS
[0075] Thermal stability is directly related to the commercial value of EPS. This study used differential scanning calorimetry (DSC) to examine the heat flow changes of KLDS1.1103EPS in the range of 20℃ to 400℃. The measurement was performed using a scanning differential calorimeter DSC. The measurement method is as follows: set the control program, set nitrogen as the test protective gas, set the temperature range to 20℃ to 400℃, set the heating rate to 10℃ / min, and observe the EPS mass change curve with temperature changes. Weigh no more than 2 mg of EPS to prevent contamination of the instrument, and scan the empty crucible for baseline calibration. See the results. Figure 4 .Depend on Figure 4It can be seen that KLDS1.1103EPS has only one exothermic peak between 20℃ and 400℃. At 193.5℃, EPS has a strong absorption peak, which may be due to the serious loss of water in EPS as the temperature rises. EPS reaches the melting point at 193.5℃. As the temperature continues to increase, there is no obvious strong exothermic peak between 193℃ and 400℃, and the heat flow changes steadily, indicating that KLDS1.1103EPS has no obvious oxidative decomposition and has good thermal stability.
[0076] Example 4 Investigation of the immunomodulatory activity of Lactobacillus bulgaricus KLDS1.1103 EPS
[0077] Referring to the literature (Shi Jialu, Li Bailiang, Yue Yingxue, et al. Anti-inflammatory effect of mixed lactobacilli on lipopolysaccharide-induced RAW264.7 macrophages [J]. Food Science and Technology, 2021, 46(05): 1-7), the ELISA kit was used to investigate the effect of KLDS1.1103EPS on the secretion of IL-6, IL-1β and TNF-α cytokines by IPEC-J2 cells. IPEC-J2 cells were cultured at 1×10 6 After the cells were subcultured in 6-well plates until 80% confluence, EPS pretreatment groups were treated with different concentrations of EPS medium suspension for 12 h, and finally treated with 1000 mol / L H2O2 for 4 h, and the secretion of IL-6, IL-1β and TNF-α was determined according to the instructions of the ELISA kit. As shown in Table 3, inflammatory factors decreased with the increase of EPS dose, and were significantly lower than those in the model group (p<0.05).
[0078] Table 3 Anti-inflammatory effect of KLDS1.1103EPS
[0079]
[0080] Example 5 Investigation of the regulatory effect of Lactobacillus bulgaricus KLDS1.1103 EPS on tight junction proteins
[0081] Referring to the literature (Yu Changsong, Jia Gang, Deng Qiuhong, et al. Effects of glucagon-like peptide-2 on lipopolysaccharide-stressed IPEC-J2 cell morphology and tight junction-related gene expression [J]. Journal of Animal Science and Veterinary Medicine, 2015, 46(4): 592-599.), porcine small intestinal epithelial cells IPEC-J2 were used as model cells, and real-time fluorescence quantitative PCR (RT-qPCR) was used to investigate the regulatory effect of KLDS1.1103EPS on tight junction proteins. The cell culture medium was 90% DMEM and 10% fetal bovine serum. The cells were digested and suspended and mixed at 1×10 6After the cells were subcultured in 6-well plates until 80% confluence, EPS pretreatment groups were treated with different concentrations of EPS medium suspension for 12 h. Finally, cells were treated with 1000 mol / L H2O2 for 4 h, and then 500 μL Buffer RL was added to lyse the cells. Instructions for the Cell RNA Isolation Kit, extract RNA, reverse transcribe and perform RT-PCR reactions in sequence. Details are as follows:
[0082] After digestion, the cells were suspended and mixed at a rate of 1 × 10 6 The cells were subcultured in 6-well plates until 80% confluence and then treated in groups. The EPS pretreatment group was pretreated with a suspension solution containing different concentrations of KLDS1.1103EPS for 12 h, and the control group and H2O2 group were pretreated with normal culture medium for 12 h. After the H2O2 group was pretreated, the cells were treated with 1000 μmol / L H2O2 for 4 h and then collected.
[0083] After the cell culture was completed, 500 μL Buffer RL was added to lyse the cells. CellRNAIsolation Kit Instructions: Extract, remove gDNA, remove impurities, elute RNA, add RNase-free 40uL to collect RNA, measure its concentration with a nucleic acid protein concentration detector, and store at -80℃ for future use.
[0084] The extracted RNA was reverse transcribed to obtain cDNA according to the instructions of the First Strand cDNA Synthesis Kit RNA kit. The reactions were all carried out on ice in an enzyme-free environment. 20 μL of the reverse transcription system was transferred to a PCR instrument and set to react at 55°C for 30 minutes. After reacting at 85°C for 5 seconds, cDNA was obtained. Its concentration was measured using a nucleic acid protein concentration detector and stored at -80°C. The reverse transcribed cDNA was subjected to RT-PCR according to the instructions of the SybrGreen qPCR Master Mix kit. The GAPDH gene was used as the internal reference gene. The primer sequences used can be found in Table 3 of the literature (Yu Changsong, Jia Gang, Deng Qiuhong, et al. Effects of glucagon-like peptide-2 on morphology and expression of tight junction-related genes in IPEC-J2 cells under lipopolysaccharide stress [J]. Journal of Animal Science and Veterinary Medicine, 2015, 46(4): 592-599.). Real-time quantitative PCR was performed using the QuantStudio 3 system, using 2 -ΔΔCt The data were analyzed by the PCR method and the relative fold changes of gene expression were calculated.
[0085] As shown in Table 4, compared with the control group, the expression levels of ZO-1 and Occludin mRNA in the model group decreased significantly (p<0.05), and EPS treatment could significantly restore the expression levels of ZO-1 mRNA and Occludin mRNA (p<0.05). The expression level of ZO-1 mRNA increased with the EPS concentration, and the 200 μg / mL EPS treatment group was significantly higher than that of the 50 μg / mL EPS treatment group, and there was no significant difference between the control group (P>0.05). The expression level of Occludin mRNA in the EPS treatment group was significantly higher than that in the model group (p<0.05), and there was no significant difference between the 50 μg / mL EPS treatment group and the control group (p>0.05). The results show that EPS can reduce intestinal barrier damage.
[0086] Table 4 Regulatory effect of KLDS1.1103EPS on tight junction proteins
[0087]
[0088] Example 6 Comparative analysis of the yield and yield of different Lactobacillus bulgaricus EPS
[0089] According to literature reports, the EPS production of Lactobacillus bulgaricus Y5 (culture temperature 40℃, fermentation time 16h, initial pH 6.0, glucose addition 2%) and Lactobacillus bulgaricus G6 (initial pH 5.5, fermentation temperature 34℃, fermentation time 36h) under the optimal conditions are 105.36mg / L and 425.7mg / L, respectively, and the fermentation efficiency is 6.585mg / L / h and 11.825mg / L / h, respectively. For details, see the literature: Wu Rongrong, Wang Min, Zhu Huixia, Wang Qian, Zhang Bailin. Optimization of exopolysaccharide synthesis conditions of Lactobacillus bulgaricus and its application in fermented milk [J]. China Dairy Industry, 2008; Liu Fang, Huang Dan, Chen Yonggui, Fan Jiang. Research on the influencing factors of high exopolysaccharide production of Lactobacillus bulgaricus G6 [J]. China Dairy Industry, 2014. The above-mentioned output and yield are much lower than the EPS output of the preparation method of Part 2 of Example 2 of the present invention (inulin content 2.1%, aerobic fermentation without stirring, fermentation time 9h, fermentation temperature 39°C, inoculation amount 10%; EPS output 693.6mg / L, EPS fermentation efficiency 77.07mg / L / h).
[0090] According to literature reports, the EPS yield of Bulgarian bacteria NCFB2772 under the optimal conditions is 907.8 mg / L (initial pH 6.5, inoculation amount 4.5%, fermentation temperature 42°C), see the literature: Wang Qingmei, Chen Qingsen, Yan Yali. Optimization of culture conditions for Lactobacillus delbrueckii subspecies bulgaricus NCFB2772 fermentation for exopolysaccharide production by response surface methodology [J]. Dairy Science and Technology, 2011. Referring to the optimal fermentation process parameters of the literature, MRS was used as the fermentation medium for Bulgarian bacteria NCFB2772, with initial pH 6.5, inoculation amount 4.5% (inoculation at 37°C), fermentation temperature 42°C, and rotation speed 0, and aerobic fermentation was performed for 9h and 18h respectively. The literature method (Grobben, GJ, et al. Analysis of the exopolysaccharides produced by Lactobacillus delbrueckii subsp. bulgaricus NCFB 2772 grown in continuous culture on glucose and fructose. Applied Microbiology and Biotechnology, 48 (1997): 516-521.) was used for precipitation with anhydrous ethanol, and the EPS obtained by fermentation was collected by centrifugation, dissolved in distilled water, dialyzed and freeze-dried, and the weight of the EPS obtained by fermentation was determined. The EPS yield (mg / L) and fermentation efficiency obtained by fermentation were calculated according to the volume of the fermentation liquid. The results showed that at 9h and 18h, the EPS yield was 536.1mg / L and 912.4mg / L, respectively, and the corresponding fermentation efficiency was 59.57mg / L / h and 50.69mg / L / h. This fermentation efficiency is lower than the fermentation efficiency (77.08mg / L / h) of the preparation method of the present invention, which is much lower than that of the preparation method of the present invention. The preparation process of the present invention (inulin content 2.1%, non-stirring aerobic fermentation, fermentation time 9h, fermentation temperature 39°C, inoculation amount 10%; EPS yield 693.6mg / L, EPS fermentation efficiency 77.07mg / L / h) 9h EPS fermentation yield is significantly higher than that of Bulgarian Bacillus NCFB2772 (about 1.29 times of the EPS produced by Bulgarian Bacillus NCFB2772 fermentation), and converted to 18h EPS fermentation yield (the process of the present invention can complete 2 batches of fermentation) is also significantly higher than that of Bulgarian Bacillus NCFB2772 (about 1.52 times of the EPS produced by Bulgarian Bacillus NCFB2772 fermentation). The preparation process of the present invention has unexpectedly higher EPS fermentation yield and fermentation efficiency of Lactobacillus bulgaricus than that of Bulgarian Bacillus NCFB2772.
Claims
1. A Lactobacillus bulgaricus, characterized in that The preservation date of the Lactobacillus bulgaricus is April 25, 2024. The preservation unit is the General Microbiology Center of the China Culture Collection Administration. The preservation address is No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing. The preservation number is CGMCC No. 30436.
2. A Lactobacillus bulgaricus according to claim 1, characterized in that The gene sequence of 16S rDNA of Lactobacillus bulgaricus is shown in SEQ ID NO.
1.
3. A Lactobacillus bulgaricus exopolysaccharide prepared by using the Lactobacillus bulgaricus according to claim 1, characterized in that: The extracellular polysaccharide is mainly composed of mannose, rhamnose, glucuronic acid, galacturonic acid, glucose, galactose, arabinose and fucose, wherein glucose and galactose account for 98.21% of the extracellular polysaccharide content, and the molar ratio of glucose to galactose is 1.053:1; the weight average molecular weight Mw of the extracellular polysaccharide is 4.06×10 4 Da, number average molecular weight Mn is 1.59×10 4 Da, the polydispersity coefficient Mw / Mn is 2.57; the infrared spectrum of the extracellular polysaccharide is 3401.85 cm -1 、2922.92cm -1 、1665.99 cm -1 、1540.70 cm -1 、1421.48 cm -1 、1243.65 cm -1 、1039.55 cm -1 、892.03 cm -1 、584.87 cm -1 There is an absorption peak at.
4. A method for preparing Lactobacillus bulgaricus exopolysaccharide prepared by Lactobacillus bulgaricus according to claim 3, wherein the preparation method is a batch fermentation method, characterized in that: The fermentation medium used in the batch fermentation method is a skim milk medium containing 2.0% to 3.0% inulin; the inoculation amount is 4% to 12%, the fermentation temperature is 35° C. to 43° C., the fermentation time is 6 to 10 hours, and the fermentation conditions are aerobic fermentation without stirring.
5. The method for preparing Lactobacillus bulgaricus exopolysaccharide prepared by Lactobacillus bulgaricus according to claim 4, characterized in that: The fermentation medium used in the batch fermentation method is a skim milk medium containing 2.0% to 2.1% inulin.
6. The method for preparing Lactobacillus bulgaricus exopolysaccharide prepared by Lactobacillus bulgaricus according to claim 5, characterized in that: The fermentation medium used in the batch fermentation method is a skim milk medium containing 2.1% inulin.
7. The method for preparing Lactobacillus bulgaricus exopolysaccharide prepared by Lactobacillus bulgaricus according to claim 4, characterized in that: The inoculation amount was 10%, the fermentation temperature was 39° C., and the fermentation time was 9 hours.
8. Use of the Lactobacillus bulgaricus exopolysaccharide prepared by the Lactobacillus bulgaricus according to claim 3 in preparing an active agent for invoking tight junction-related proteins in mammalian cells.
9. Use of the Lactobacillus bulgaricus exopolysaccharide prepared by Lactobacillus bulgaricus according to claim 8 in preparing an active agent for invoking tight junction-related proteins in mammalian cells, characterized in that: The tight junction-associated proteins at least include Occludin protein and / or ZO-1 protein.
10. Use of the Lactobacillus bulgaricus exopolysaccharide prepared by Lactobacillus bulgaricus according to claim 8 in preparing an active agent for invoking tight junction-related proteins in mammalian cells, characterized in that: The active agent is an oral preparation.
Citation Information
Cited By
Lactobacillus bulgaricus CB-01 with high exopolysaccharide yield and application of lactobacillus bulgaricus CB-01
CN118792214A
